Summary
Ketamine is a very versatile inexpensive drug and plays an invaluable role in the developing world. In regions where access and funding for a wider range of drugs is problematic, its broad range of clinical applications is ideal. Its good safety profile and ease of storage makes it ideal for use in areas where refrigerators, complex monitoring, electricity and oxygen may all be in short supply or unreliable. Ketamine is also finding increasing use in both the acute and chronic pain settings and research is still ongoing into a potential neuroprotective effect for ketamine in brain injury.
This is a repository copy of Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH) : a stepped-wedge cluster-randomised trial. Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH) : a stepped-wedge cluster-randomised trial. The Lancet. ISSN 0140-6736 https://doi.org/10.1016/S0140-6736(18)32521-2 eprints@whiterose.ac.uk https://eprints.whiterose.ac.uk/
ReuseThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long as you credit the authors, but you can't change the article in any way or use it commercially. More information and the full terms of the licence here: https://creativecommons.org/licenses/
Implications of all the available evidenceDespite the success of some smaller projects, there was no survival benefit from a national quality improvement programme to implement a care pathway for patients undergoing emergency abdominal surgery. To succeed, large national quality improvement programmes need to allow for differences between hospitals and ensure teams have both the time and resources needed to improve patient care.
Patients exposed to a surgical safety checklist experience better postoperative outcomes, but this could simply reflect wider quality of care in hospitals where checklist use is routine.
SummaryIn this study we developed a model lung to compare the effectiveness of ventilation using four different cricothyrotomy devices. The Ravussin 13G cannula (VBM Medical), the Quicktrach cannula 4 mm ID (VBM Medical), the Melker cannula 6 mm ID (Cook) and a cuffed tracheal tube 6 mm ID were used in turn to ventilate the model lung through a cricothyrotomy over a range of upper airway resistances. The 6 mm cuffed tracheal tube provided consistently good ventilation independent of upper airway resistance. The 6 mm ID Melker device provided at least reasonable and at best very good ventilation, whatever the patency of the upper airway. The Ravussin cannula could ventilate well with the jet ventilator with low upper airway resistance but could not ventilate at all with complete upper airway obstruction. The Quicktrach performed poorly with low upper airway resistance but well with increased upper airway resistance. With its easier insertion, fewer complications compared to a surgical cricothyrotomy, and the ability to use it with a standard anaesthetic circuit, the authors feel that the 6 mm Melker canula is the technique of choice for emergency trans-tracheal ventilation.
We have studied response times of 30 anaesthetists to a standardized episode of arterial oxygen desaturation in a simulated patient, randomized to the use of either a fixed or variable pitch pulse oximeter. We wished to determine if a variable auditory signal was important in detecting adverse events. A variable pitch pulse signal had a shorter time to recognition of desaturation (P < 0.0001), with a mean response time of 32 s, compared with 129 s for the fixed pitch signal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.